高良姜素含氮衍生物的合成及其抗肿瘤活性  被引量:4

Synthesis and Antitumor Activities of Nitrogen-Containing Galangin Derivatives

在线阅读下载全文

作  者:罗焱[1] 尤朋涛[1] 杨敏[2] 刘焱文[1] 刘丹[1] 

机构地区:[1]湖北中医药大学中药资源与中药化学湖北省重点实验室 [2]湖北中医药大学药学院,武汉430065

出  处:《天然产物研究与开发》2017年第4期575-578,共4页Natural Product Research and Development

基  金:国家自然科学基金(31400302);湖北中医药大学"青苗计划"(2015ZXX015)

摘  要:高良姜素是一种天然来源的黄酮醇类化合物,药理作用广泛,但尚未有关于其结构修饰的研究报道。本文以高良姜素为原料,设计、合成了5个高良姜素含氮衍生物,并对其结构进行1H NMR、13C NMR及MS表征;然后采用MTT法测试结构修饰产物的抗肿瘤活性,结果表明化合物2-苯基-3,5,7-三羟基-8-(吗啉甲基)-4H-色烯-4-酮(2c)和2-苯基-3,5,7-三羟基-8-(哌嗪-1-甲基)-4H-色烯-4-酮(2d)对人前列腺癌PC-3细胞株的增殖抑制活性(IC_(50):11.37和13.57μmol/L)显著优于高良姜素(IC50:41.66μmol/L),分别提高了3.66倍和3.07倍;化合物2-苯基-3,5,7-三羟基-8-(哌嗪-1-甲基)-4H-色烯-4-酮(2d)对人结肠癌LOVO细胞株的增殖抑制活性较高良姜素提高了5.22倍。该系列衍生物的抗肿瘤活性的增强可能与8-位上含氮杂环的引入有关。Galangin, a naturally occurring bioflavonoid, has a variety of pharmacological effects. However, few literatures on its structural modification have been reported. In the present study, five nitrogen-containing galangin derivatives were designed and synthesized, the structures of the synthesized derivatives were characterized by 1H NMR, 13C NMR and MS,then the antitumor activities of these derivatives were assayed by MTT method. The results showed that the anti-pro- liferative activity against human prostatic carcinoma cell line PC-3 of 2-phenyl-3,5,7-trihydroxy-8-( morpholinomethyl)- 4H-chromen-4-one 2c ( IC50 11.37 μmol/L) and 2-phenyl-3,5,7-trihydroxy-8-( piperazin-1-ylmethyl ) -4H-chromen-4- one 2d(IC50 :13.57μmoL/L) were more potent than galangin (IC50:41.66μmoL/L) while the compound 2d exhibited the highest anti-proliferative activity against human colon cancer cell line Lovo with about 5.22-fold more potent than ga- langin. The increase of the antitumor activities of these derivatives was possibly related to the introduction of N-contai- ning heterocyclic ring into the 8-site of galangin.

关 键 词:高良姜素 结构修饰 含氮杂环化合物 抗肿瘤活性 

分 类 号:R914[医药卫生—药物化学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象